Hyperglycemia associated mTOR activation leads to glomerular changes like hypertrophy, basement membrane thickening and mesangial proliferation, processes that can be ameliorated by rapamycin, a specific inhibitor of mTOR [3, 4]. Here, MTOR is linked to Hyperglycemia.